AAAAAA
Results:
1-18
|
Results: 18
Authors:
Regrigny, O
Delagrange, P
Scalbert, E
Atkinson, J
Chillon, JM
Citation: O. Regrigny et al., Melatonin increases pial artery tone and decreases the lower limit of cerebral blood flow autoregulation, FUN CL PHAR, 15(4), 2001, pp. 233-238
Authors:
Regrigny, O
Dupuis, F
Atkinson, J
Liminana, P
Scalbert, E
Delagrange, P
Chillon, JM
Citation: O. Regrigny et al., Cerebral arteriolar structure and function in pinealectomized rats, AM J P-HEAR, 281(4), 2001, pp. H1476-H1480
Authors:
Yang, Q
Scalbert, E
Delagrange, P
Vanhoutte, PM
O'Rourke, ST
Citation: Q. Yang et al., Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries, AM J P-HEAR, 280(1), 2001, pp. H76-H82
Melatonin potentiates NE-induced vasoconstriction without augmenting cytosolic calcium concentration
Authors:
Vandeputte, C
Giummelly, P
Atkinson, J
Delagrange, P
Scalbert, E
Capdeville-Atkinson, C
Citation: C. Vandeputte et al., Melatonin potentiates NE-induced vasoconstriction without augmenting cytosolic calcium concentration, AM J P-HEAR, 280(1), 2001, pp. H420-H425
Authors:
Tom, B
De Vries, P
Heiligers, JPC
Willems, EW
Scalbert, E
Delagrange, P
Saxena, P
Citation: B. Tom et al., The lack of vasoconstrictor effect of the pineal hormone melatonin in an animal model predictive of antimigraine activity, CEPHALALGIA, 21(6), 2001, pp. 656-663
Authors:
Schann, S
Bruban, V
Pompermayer, K
Feldman, J
Pfeiffer, B
Renard, P
Scalbert, E
Bousquet, P
Ehrhardt, JD
Citation: S. Schann et al., Synthesis and biological evaluation of pyrrolinic isosteres of rilmenidine. Discovery of cis-/trans-dicyclopropylmethyl-(4,5-dimethyl-4,5-dihydro-3H-pyrrol-2-yl)-amine (LNP 509), an I-1 imidazoline receptor selective ligand with hypotensive activity, J MED CHEM, 44(10), 2001, pp. 1588-1593
Authors:
Ferry, G
Gillet, L
Bruneau, V
Banales, JM
Beauverger, P
Coge, F
Galizzi, JP
Scalbert, E
Okamoto, T
Urata, H
Boutin, JA
Citation: G. Ferry et al., Development of new assays and improved procedures for the purification of recombinant human chymase, EUR J BIOCH, 268(22), 2001, pp. 5885-5893
Authors:
Sauzeau, V
Le Mellionnec, E
Bertoglio, J
Scalbert, E
Pacaud, P
Loirand, G
Citation: V. Sauzeau et al., Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase, CIRCUL RES, 88(11), 2001, pp. 1102-1104
Authors:
Richard, V
Hurel-Merle, S
Scalbert, E
Ferry, G
Lallemand, F
Bessou, JP
Thuillez, C
Citation: V. Richard et al., Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries, CIRCULATION, 104(7), 2001, pp. 750-752
Authors:
Bruban, V
Feldman, J
Greney, H
Dontenwill, M
Schann, S
Jarry, C
Payard, M
Boutin, J
Scalbert, E
Pfeiffer, B
Renard, P
Vanhoutte, P
Bousquet, P
Citation: V. Bruban et al., Respective contributions of alpha-adrenergic and non-adrenergic mechanismsin the hypotensive effect of imidazoline-like drugs, BR J PHARM, 133(2), 2001, pp. 261-266
Authors:
Sauzeau, V
Le Jeune, H
Toumaniantz, CC
Vaillant, N
Gadeau, AP
Desgranges, C
Scalbert, E
Chardin, P
Pacaud, P
Loirand, G
Citation: V. Sauzeau et al., P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes, AM J P-HEAR, 278(6), 2000, pp. H1751-H1761
Authors:
Ting, N
Thambyraja, A
Sugden, D
Scalbert, E
Delagrange, P
Wilson, VG
Citation: N. Ting et al., Pharmacological studies on the inhibitory action of melatonin and putativemelatonin analogues on porcine vascular smooth muscle, N-S ARCH PH, 361(3), 2000, pp. 327-333
Authors:
Cooper, ME
Thallas, V
Forbes, J
Scalbert, E
Sastra, S
Darby, I
Soulis, T
Citation: Me. Cooper et al., The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation, DIABETOLOG, 43(5), 2000, pp. 660-664
Authors:
Regrigny, O
Delagrange, P
Scalbert, E
Lartaud-Idjouadiene, I
Atkinson, J
Chillon, JM
Citation: O. Regrigny et al., Effects of melatonin on rat pial arteriolar diameter in vivo, BR J PHARM, 127(7), 1999, pp. 1666-1670
Authors:
Ting, KN
Blaylock, NA
Sugden, D
Delagrange, P
Scalbert, E
Wilson, VG
Citation: Kn. Ting et al., Molecular and pharmacological evidence for MTI melatonin receptor subtype in the tail artery of juvenile Wistar rats, BR J PHARM, 127(4), 1999, pp. 987-995
Authors:
Scalbert, E
Guardiola-Lemaitre, B
Delagrange, P
Citation: E. Scalbert et al., Melatonin and regulation of the cardiovascular system, THERAPIE, 53(5), 1998, pp. 459-465
Authors:
Witte, K
Grebmer, W
Scalbert, E
Delagrange, P
Guardiola-Lemaitre, B
Lemmer, B
Citation: K. Witte et al., Effects of melatoninergic agonists on light-suppressed circadian rhythms in rats, PHYSL BEHAV, 65(2), 1998, pp. 219-224
Authors:
Velasquez, MT
Bhathena, SJ
Striffler, JS
Thibault, N
Scalbert, E
Citation: Mt. Velasquez et al., Role of angiotensin-converting enzyme inhibition in glucose metabolism andrenal injury in diabetes, METABOLISM, 47(12), 1998, pp. 7-11
Risultati:
1-18
|